Form 4: Concentra Group Holdings Executive Receives 40,000 Shares of Restricted Stock

Michael D. Rhine, an executive at Concentra Group Holdings, was granted 40,000 shares of restricted stock on November 26, 2024.

Summary

• Michael D. Rhine, Executive Vice President and Chief Operating Officer at Concentra Group Holdings, received 40,000 shares of restricted stock.
• The grant occurred on November 26, 2024.
• The restricted stock will vest in equal annual installments over four years.
• Following the transaction, Mr. Rhine beneficially owns a total of 40,098 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally positive for aligning management with shareholder interests. There are no negative implications.

Positives

• The grant of restricted stock aligns executive interests with the long-term performance of the company.
• The vesting schedule encourages continued service and contribution from the executive.

Management Comments

• The document includes the title of Michael D. Rhine as Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine.

Industry Context

Stock grants are a common form of executive compensation in publicly traded companies, used to incentivize performance and align management interests with shareholders.

Comparison to Industry Standards

• Restricted stock grants are a standard practice for executive compensation across various industries.
• The four-year vesting schedule is also a common practice to ensure long-term commitment from the executive.
• The specific value of the grant is not disclosed, making a direct comparison to other companies difficult without additional information.

Stakeholder Impact

• The stock grant may have a minor positive impact on shareholder sentiment by aligning executive interests with company performance.

Key Dates

Keywords

restricted stock, executive compensation, stock grant, insider transaction, Concentra Group Holdings, Michael D. Rhine